Biomed Lublin S.A. products

Name Of The Medicinal Product; Onko BCG 50; Powder and solvent for suspension for intravesical use; BCG ad immunocurationem; BCG for immunotherapy.

Name Of The Medicinal Product; DISTREPTAZA; Streptokinase + Streptodornase; 15000 IU + 1250 IU. Rectal suppositories.

Name of the Medicinal Product Gamma anty-D 50, 50 micrograms/ml Solution for injection. Qualitative and Quantitative Composition: 1 ml of the solution consists of: Human anti-D immunoglobulin 50 micrograms (250 IU) . Human protein content not less than 30 mg. Each ampoule contains 50 micrograms (250 IU) human anti-D immunoglobulin. The IgA content is not more than 50 micrograms/ml. The product is produced from the plasma of human donors. For the full list of excipients, see section 6.1.

Name of the Medicinal Product:BioTrombina 400. Powder and solvent for making solution for topical use, 400 IU, 200 IU/m1, Thrombinum bovine. Qualitative and Quantitative Composition: Each ampoule or vial with the powder contains: 400 IU of bovine thrombin. 1 ml of the solution (after reconstitution in 2 ml of the solvent) contains: 200 IU of bovine thrombin. For the full list of excipients, refer to item 6. I.

Onko BCG 100. Powder and solvent for suspension for intravesical use. BCG ad immunocurationem. BCG for immunotherapy.